← Leaderboards
George F Sawaya
University Of California San Francisco
$3,809,723
Attributed
$5,136,282
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $713.7K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,136,282 · 4
By mechanism
R01$4,854,975 · 2
M01$197,137 · 1
K08$84,170 · 1
Top collaborators
- Michael J Silverberg4 shared
Most similar at University Of California San Francisco
Same institution · by research overlap
- Joel Palefsky$28,104,336
- Douglas Allen Corley$15,364,838
- Jennifer S Haas$18,455,741
- Anna-Barbara None Moscicki$36,508,762
- Laura J Esserman$22,971,436
Others in their field
Top investigators on “Women&Apos”
- Steven T Dekosky · Rush University Medical Center$18,932,347
- Jose A Luchsinger · Columbia University Health Sciences$16,383,484
- Corette B Parker · Research Triangle Institute$14,403,014
- Kejal Kantarci · Mayo Clinic Rochester$8,220,660
- George R. Saade · Research Triangle Institute$7,301,796
- Philip Greenland · Research Triangle Institute$7,301,796
Research focus
Women&AposHuman PapillomavirusCervicalCervical Cancer PreventionScreeningCervical Cancer ScreeningCytologyFutureWomanS GroupEquilibriumRandomized TrialMalignant Neoplasm Of Cervix UteriCost Effectiveness AnalysisCancer RiskHuman Old Age (65+)Decision ModelingDiagnostic ProcedureCancer EpidemiologyCancer DiagnosisAmerican Cancer SocietyDiscipline Of ObstetricsClinically SignificantCessation Of Life
Grant awards (10)
Cervical cancer screening after age 65 in the era of HPV testing: estimating benefits and harms of screening cessation and continuation$651,022
R01 · FY2025 · CA · contact PI
Cervical cancer screening after age 65 in the era of HPV testing: estimating benefits and harms of screening cessation and continuation$633,588
R01 · FY2024 · CA · contact PI
Cervical cancer screening after age 65 in the era of HPV testing: estimating benefits and harms of screening cessation and continuation$654,794
R01 · FY2023 · CA · contact PI
Cervical cancer screening after age 65 in the era of HPV testing: estimating benefits and harms of screening cessation and continuation$713,715
R01 · FY2022 · CA · contact PI
Using comparative effectiveness analyses to optimize cervical cancer screening$527,836
R01 · FY2016 · CA · contact PI
Using comparative effectiveness analyses to optimize cervical cancer screening$546,158
R01 · FY2015 · CA · contact PI
Using comparative effectiveness analyses to optimize cervical cancer screening$538,971
R01 · FY2014 · CA · contact PI
Using comparative effectiveness analyses to optimize cervical cancer screening$588,891
R01 · FY2013 · CA · contact PI
REPLENS GEL PILOT STUDY$197,137
M01 · FY2005 · RR
CERVICAL CANCER SCREENING IN OLDER WOMEN$84,170
K08 · FY2000 · CA